PIK3R2 and cardiovascular disorder: In addition, studies have suggested that miR‐126 targets PIK3R2 to inhibit endothelial progenitor cells (EPC) in endothelial mesenchymal transition (EndMT), which may become a therapeutic tool for cardiovascular diseases [17].